Canna~Fangled Abstracts

The Endocannabinoid System Contributes to Electroacupuncture Analgesia

By February 18, 2021March 9th, 2021No Comments
An increasing body of scientific evidence details how electroacupuncture (EA) treatments achieve effective analgesia and reduce inflammation by modulating cannabinoid signaling.
Review
. 2021 Feb 18;14:594219.

doi: 10.3389/fnins.2020.594219. eCollection 2020.

Iona J MacDonald 1, Yi-Hung Chen 1 2 3
Affiliations 

Abstract

The extensive involvement of the endocannabinoid system (ECS) in vital physiological and cognitive processes of the human body has inspired many investigations into the role of the ECS and drugs, and therapies that target this system and its receptors. Activation of cannabinoid receptors 1 and 2 (CB1 and CB2) by cannabinoid treatments, including synthetic cannabinoids, alleviates behavioral responses to inflammatory and neuropathic pain. An increasing body of scientific evidence details how electroacupuncture (EA) treatments achieve effective analgesia and reduce inflammation by modulating cannabinoid signaling, without the adverse effects resulting from synthetic cannabinoid administration. CB1 receptors in the ventrolateral area of the periaqueductal gray are critically important for the mechanisms of the EA antinociceptive effect, while peripheral CB2 receptors are related to the anti-inflammatory effects of EA. This review explores the evidence detailing the endocannabinoid mechanisms involved in EA antinociception.

 

Keywords: analgesia, cannabinoid receptors, electroacupuncture, endocannabinoid system, pain

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

SCHEME 1

References

    1. Acharya N., Penukonda S., Shcheglova T., Hagymasi A. T., Basu S., Srivastava P. K. (2017). Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Proc. Natl. Acad. Sci. U.S.A. 114 5005–5010. 10.1073/pnas.1612177114 – DOI – PMC – PubMed
    1. Aizpurua-Olaizola O., Elezgarai I., Rico-Barrio I., Zarandona I., Etxebarria N., Usobiaga A. (2017). Targeting the endocannabinoid system: future therapeutic strategies. Drug Discov. Today 22 105–110. 10.1016/j.drudis.2016.08.005 – DOI – PubMed
    1. Almeida R. T., Romero T. R., Romero M. G., de Souza G. G., Perez A. C., Duarte I. D. (2016). Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats. Pharmacol. Rep. 68 1095–1101. 10.1016/j.pharep.2016.07.004 – DOI – PubMed
    1. Baeumler P. I., Conzen P., Irnich D. (2019). High temporal summation of pain predicts immediate analgesic effect of acupuncture in chronic pain patients-a prospective cohort study. Front. Neurosci. 13:498. – PMC – PubMed
    1. Baeumler P. I., Fleckenstein J., Takayama S., Simang M., Seki T., Irnich D. (2014). Effects of acupuncture on sensory perception: a systematic review and meta-analysis. PLoS One 9:e113731. 10.1371/journal.pone.0113731 – DOI – PMC – PubMed

Publication types

Leave a Reply